OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of NF‐κB is required for oleanolic acid to downregulate PD‐L1 by promoting DNA demethylation in gastric cancer cells
Xirong Lu, Yuyi Li, Wei Yang, et al.
Journal of Biochemical and Molecular Toxicology (2020) Vol. 35, Iss. 1
Closed Access | Times Cited: 24

Showing 24 citing articles:

Terpenoids’ anti-cancer effects: focus on autophagy
Chirine El‐Baba, Amro Baassiri, Georges Kiriako, et al.
APOPTOSIS (2021) Vol. 26, Iss. 9-10, pp. 491-511
Closed Access | Times Cited: 125

Drug repurposing for cancer therapy
Ying Xia, Ming Sun, Hai Huang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 107

Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer
Yuanda Liu, Changfeng Li, Yaoping Lu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 90

Anti-PD-1/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations
Xiang Chen, Lingjuan Chen, Xiaofei Peng, et al.
Translational Oncology (2023) Vol. 40, pp. 101851-101851
Open Access | Times Cited: 24

Xiaojianzhong decoction attenuates gastric mucosal injury by activating the p62/Keap1/Nrf2 signaling pathway to inhibit ferroptosis
Juan Chen, Jiaxiang Zhang, Ting Chen, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113631-113631
Open Access | Times Cited: 29

The signaling pathways and targets of natural products from traditional Chinese medicine treating gastric cancer provide new candidate therapeutic strategies
Yile Liao, Yu Gui, Qingzhou Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188998-188998
Closed Access | Times Cited: 20

PD-L1: Biological mechanism, function, and immunotherapy in gastric cancer
Yingzi Zhang, Yan Yang, Yiran Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23

Traditional Chinese medicine for transformation of gastric precancerous lesions to gastric cancer: A critical review
Yi-Lin Zhong, Peng-Qian Wang, Dan-Li Hao, et al.
World Journal of Gastrointestinal Oncology (2023) Vol. 15, Iss. 1, pp. 36-54
Open Access | Times Cited: 15

Epigenetic effects of herbal medicine
Yu-Yao Wu, Yan‐Ming Xu, Andy T. Y. Lau
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 12

Exploring the therapeutic potential of oleanolic acid and its derivatives in cancer treatment: a comprehensive review
Rachel Savio D’Mello, Vividh Mendon, Padmini Pai, et al.
3 Biotech (2025) Vol. 15, Iss. 3
Open Access

Interplay between inflammasomes and PD-1/PD-L1 and their implications in cancer immunotherapy
Z.M. Jiao, Jun Zhang
Carcinogenesis (2023) Vol. 44, Iss. 12, pp. 795-808
Closed Access | Times Cited: 9

Understanding Inflammasomes and PD-1/PD-L1 Crosstalk to Improve Cancer Treatment Efficiency
Anaïs Perrichet, François Ghiringhelli, Cédric Rébé
Cancers (2020) Vol. 12, Iss. 12, pp. 3550-3550
Open Access | Times Cited: 21

Epigenetic modifications: Critical participants of the PD‑L1 regulatory mechanism in solid tumors (Review)
Xiaoran Ma, Jibiao Wu, Bin Wang, et al.
International Journal of Oncology (2022) Vol. 61, Iss. 5
Open Access | Times Cited: 13

Application of Traditional Chinese Medicine in Inhibiting the PD-1/PD-L1 Pathway in the Treatment of Gastric and Colon Cancers
Xinghui Zhu, ShuJie Wang, Lie Wen Xie, et al.
Natural Product Communications (2024) Vol. 19, Iss. 6
Open Access | Times Cited: 2

The impact of sarcopenia on the efficacy of PD-1 inhibitors in non-small cell lung cancer and potential strategies to overcome resistance
Zhenchao Liu, Tianxiang Lei, Yunliang Guo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2

Comprehensive Review: Unveiling the Pro-Oncogenic Roles of IL-1ß and PD-1/PD-L1 in NSCLC Development and Targeting Their Pathways for Clinical Management
Dani Ran Castillo, Won Jin Jeon, Daniel Park, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11547-11547
Open Access | Times Cited: 4

Salvia miltiorrhiza in cancer: Potential role in regulating MicroRNAs and epigenetic enzymes
Lu Meng, Xintian Lan, Xi Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 5

Targeting Notch-Driven Cytokine Secretion: Novel Therapies for Triple Negative Breast Cancer
Wanda Marini, Brooke E. Wilson, Michael Reedijk
DNA and Cell Biology (2022) Vol. 42, Iss. 2, pp. 73-81
Closed Access | Times Cited: 5

Chinese Medicines and Natural Medicine as Immunotherapeutic Agents for Gastric Cancer: Recent Advances
Zhipeng Zhang, Ziqi Chen, Zujun Que, et al.
Cancer Reports (2024) Vol. 7, Iss. 9
Open Access

Antitumour activity of oleanolic acid: A systematic review and meta‑analysis
Ying Zeng, Zhonglian Wang, Jing Zhang, et al.
Oncology Letters (2024) Vol. 28, Iss. 6
Open Access

Application and Development of Natural Plant Metabolite Oleanolic Acid in the Nano Era
Kun Wang, Qinyue Lu, Xiang Cao, et al.
Agriculture (2022) Vol. 12, Iss. 12, pp. 2142-2142
Open Access | Times Cited: 2

Epigenetic Regulation of Cancer by Natural Touch: Phytochemicals and Epigenetic Regulation
Bakiye Göker Bağca, Çığır Biray Avcı
(2022), pp. 241-262
Closed Access

Page 1

Scroll to top